EUVIMEDEUVIMED entdecken
Open Access

Rare Genetic Variants in LDLR , APOB , and PCSK9 Are Associated With Aortic Stenosis

Joel T Rämö iD, Sean J Jurgens iD, Shinwan Kany iD, Seung Hoan Choi, Xin Wang iD, Andrey N Smirnov, Samuel F Friedman iD, Mahnaz Maddah iD, Shaan Khurshid iD, Patrick T Ellinor iD, James P Pirruccello

Circulation · 2024

DOI: 10.1161/circulationaha.124.070982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2024. Verfasst von Joel T Rämö und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Disease Initiative (J.T.R., S.J.J., S. Kany, X.W., S. Khurshid, P.T.E., J.P.P.), Cambridge, MA. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Aortic Valve Stenosis, Receptors, LDL, Apolipoprotein B-100. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite a proposed causal role for LDL-C (low-density lipoprotein cholesterol) in aortic stenosis (AS), randomized controlled trials of lipid-lowering therapy failed to prevent severe AS. We aimed to assess the impact on AS and peak velocity across the aortic valve conferred by lifelong alterations in LDL-C levels mediated by protein-disrupting variants in 3 clinically significant genes for LDL (low-density lipoprotein) metabolism ( LDLR , APOB , and PCSK9 ). METHODS: We used sequencing data and electronic health records from UK Biobank (UKB) and All of Us and magnetic resonance imaging data from UKB. We identified predicted protein-disrupting variants with the Loss Of Function Transcript Effect Estimator (LOFTEE) and AlphaMissense algorithms and evaluated their associations with LDL-C and peak velocity across the aortic valve (UK Biobank), as well as diagnosed AS and aortic valve replacement (UK Biobank and All of Us). RESULTS: We included 421 049 unrelated participants (5621 with AS) in UKB and 195 519 unrelated participants (1087 with AS) in All of Us. Carriers of protein-disrupting variants in LDLR had higher mean LDL-C (UKB: +42.6 mg/dL; P =4.4e-237) and greater risk of AS (meta-analysis: odds ratio, 3.52 [95% CI, 2.39–5.20]; P =2.3e-10) and aortic valve replacement (meta-analysis: odds ratio, 3.78 [95% CI, 2.26–6.32]; P =4.0e-7). Carriers of protein-disrupting variants in APOB or PCSK9 had lower mean LDL-C (UKB: –32.3 mg/dL; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9Aortic Valve StenosisReceptors, LDLApolipoprotein B-100HumansFemaleMaleAgedMiddle AgedGenetic VariationCholesterol, LDLGenetic Predisposition to DiseaseAortic Valve

Stichwörter der Autor:innen

aortic valve stenosischolesterolgeneticslipidslipoproteins, LDLmagnetic resonance imagingreceptors, LDL

Substanzen

Proprotein Convertase 9PCSK9 protein, humanReceptors, LDLAPOB protein, humanLDLR protein, humanApolipoprotein B-100Cholesterol, LDL

Autor:innen und Institutionen

  • Cardiovascular Disease Initiative (J.T.R., S.J.J., S. Kany, X.W., S. Khurshid, P.T.E., J.P.P.), Cambridge, MA.
  • Broad Institute of MIT and Harvard (J.T.R., S.J.J., S. Kany, X.W., S. Khurshid, P.T.E., J.P.P, A.N.S., S.F.F., M.M.), Cambridge, MA.
  • Department of Medicine, Brigham and Women's Hospital, Boston, MA (J.T.R.).
  • Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki (J.T.R.).
  • Cardiovascular Research Center (J.T.R., S.J.J., S. Kany, S. Khurshid, P.T.E.), Massachusetts General Hospital, Boston.
  • Department of Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Failure & Arrhythmias, Amsterdam University Medical Center, University of Amsterdam, The Netherlands (S.J.J.).

ORCID-Profile: Joel T Rämö, Sean J Jurgens, Shinwan Kany, Xin Wang, Samuel F Friedman, Mahnaz Maddah, Shaan Khurshid, Patrick T Ellinor

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • Wellcome Trust
  • NINDS NIH HHS
  • Sigrid Juselius Foundation
  • Dutch Heart Foundation
  • Deutsche Forschungsgemeinschaft
  • National Institutes of Health

Zitieren

APA

Rämö, J. T., Jurgens, S. J., Kany, S., Choi, S. H., Wang, X., Smirnov, A. N., Friedman, S. F., Maddah, M., Khurshid, S., Ellinor, P. T., & Pirruccello, J. P. (2024). Rare Genetic Variants in LDLR , APOB , and PCSK9 Are Associated With Aortic Stenosis. Circulation. https://doi.org/10.1161/circulationaha.124.070982

Vancouver

Rämö JT, Jurgens SJ, Kany S, Choi SH, Wang X, Smirnov AN, et al. Rare Genetic Variants in LDLR , APOB , and PCSK9 Are Associated With Aortic Stenosis. Circulation. 2024. doi:10.1161/circulationaha.124.070982

BibTeX
@article{Rm2024,
  author = {Rämö, Joel T and Jurgens, Sean J and Kany, Shinwan and Choi, Seung Hoan and Wang, Xin and Smirnov, Andrey N and Friedman, Samuel F and Maddah, Mahnaz and Khurshid, Shaan and Ellinor, Patrick T and Pirruccello, James P},
  title = {Rare Genetic Variants in LDLR , APOB , and PCSK9 Are Associated With Aortic Stenosis},
  journal = {Circulation},
  year = {2024},
  doi = {10.1161/circulationaha.124.070982}
}
Kostenlos starten →